SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+11.02%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(+42%)
Cap. Flow
+$51M
Cap. Flow
% of AUM
27.54%
Top 10 Holdings %
Top 10 Hldgs %
73.08%
Holding
35
New
14
Increased
11
Reduced
4
Closed
6
Top Buys
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$15.4M |
| 2 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$13.2M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$12.5M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$10.8M |
| 5 |
Ovid Therapeutics
OVID
|
$9.98M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$32.4M |
| 2 |
AYTU BioPharma
AYTU
|
$7.87M |
| 3 |
SCYNEXIS
SCYX
|
$5.24M |
| 4 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$4.83M |
| 5 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$3.1M |
Sector Composition
| 1 | Healthcare | 88.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGTC
26
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $910K | 0.49% |
+179,511
| New | +$910K |
|
27
Galapagos
GLPG
$2.06B
| $771K | 0.42% |
+10,000
| New | +$771K |
|
|
BWAY
28
Brainsway
BWAY
$296M
| $498K | 0.27% |
+55,181
| New | +$498K |
|
|
ONCS
29
DELISTED
OncoSec Medical Incorporated
ONCS
| $452K | 0.24% |
+94,783
| New | +$452K |
|
|
NEOS
30
DELISTED
Neos Therapeutics, Inc
NEOS
| – | – |
-4,962,657
| Closed | -$3.1M |
|
31
VistaGen Therapeutics
VTGN
$113M
| – | – |
-500,000
| Closed | -$970K |
|
|
32
SCYNEXIS
SCYX
$35.2M
| – | – |
-685,000
| Closed | -$5.24M |
|
|
33
Ligand Pharmaceuticals
LGND
$3.25B
| – | – |
-326,100
| Closed | -$32.4M |
|
34
Eledon Pharmaceuticals
ELDN
$155M
| – | – |
-167,333
| Closed | -$2.58M |
|
35
Cumberland Pharmaceuticals
CPIX
$54M
| – | – |
-188,703
| Closed | -$557K |
|